Almatni Sally, Alsultan Mohammad, Anan Mohamed Taher, Alourfi Zaynab
Department of Endocrinology, Damascus University- Faculty of Medicine, Damascus, Syria.
Department of Nephrology, Damascus University- Faculty of Medicine, Damascus, Syria.
Ann Med Surg (Lond). 2022 Mar 10;76:103457. doi: 10.1016/j.amsu.2022.103457. eCollection 2022 Apr.
This study aims to identify the prevalence of 25OHD deficiency in Syrian patients and investigate the relationship with obesity and lipid profile.
A retrospective cohort study consisted of 201 patients of age >10 years, who referred to Al Assad and Al Mouwasat University Hospitals, Damascus, Syria from Oct/2020 to Oct/2021. The data was analyzed by using linear regressions and produced a matrix of correlations with significant equations between study variables.
Firstly, participants were divided depending on 25OHD levels, where 92.5% of patients had 25OHD <30 ng/mL. Inverse correlation between 25OHD and BMI (P ≤ 0.001) was observed, where severe 25OHD deficiency group had higher BMI (27.40 ± 7.22 kg/m) and higher levels of Chol (211 ± 67.12 mg/dl) than in sufficiency group.Secondly, participants were divided depending on BMI. Higher BMI associated with lower levels of 25OHD. Moreover, we derived that every increase in 25OHD by 1 ng/mL results in decrease of BMI by 0.26 kg/m (P ≤ 0.001) and results in decrease of Chol by 1.54 mg/dl (P ≤ 0.004).
A high prevalence of 25OHD deficiency was observed in this sample of Syrian patients. There is an inverse correlation between 25OHD and BMI regardless of age and gender. Moreover, the equation, that derived between 25OHD and BMI, represents a beneficial and an inexpensive tool in clinical practice to minimize testing of 25OHD by predicting its deficiency based on BMI and supports the impact of 25OHD supplementation for reduce BMI.
本研究旨在确定叙利亚患者中25羟维生素D(25OHD)缺乏症的患病率,并调查其与肥胖和血脂谱的关系。
一项回顾性队列研究纳入了201例年龄大于10岁的患者,这些患者于2020年10月至2021年10月转诊至叙利亚大马士革的阿萨德大学医院和穆瓦萨特大学医院。通过线性回归分析数据,并生成了研究变量之间具有显著方程的相关矩阵。
首先,根据25OHD水平对参与者进行分组,其中92.5%的患者25OHD<30 ng/mL。观察到25OHD与体重指数(BMI)呈负相关(P≤0.001),重度25OHD缺乏组的BMI(27.40±7.22 kg/m)和胆固醇(Chol)水平(211±67.12 mg/dl)高于充足组。其次,根据BMI对参与者进行分组。较高的BMI与较低的25OHD水平相关。此外,我们得出,25OHD每增加1 ng/mL,BMI降低0.26 kg/m(P≤0.001),Chol降低1.54 mg/dl(P≤0.004)。
在该叙利亚患者样本中观察到25OHD缺乏症的高患病率。无论年龄和性别,25OHD与BMI之间均呈负相关。此外,25OHD与BMI之间得出的方程代表了临床实践中一种有益且廉价的工具,通过基于BMI预测25OHD缺乏来尽量减少其检测,并支持补充25OHD对降低BMI的影响。